TickerFactsScreenerDevelopers

PALISADE BIO, INC. (PALI) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $4.90M2009: $2.31M2010: $9.26M2011: $2.35M2012: $7.44M2013: $16.85M2014: $12.52M2015: $4.72M2016: $15.19M2017: $6.67M2018: $5.79M2019: $5.11M2020: $713.0K2021: $10.49M2022: $12.38M2023: $12.43M2024: $9.82M2025: $133.38M$133.38M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$133.38M+1258.2%
2024$9.82M-21.0%
2023$12.43M+0.4%
2022$12.38M+18.0%
2021$10.49M+1371.9%
2020$713.0K-86.1%
2019$5.11M-11.6%
2018$5.79M-13.3%
2017$6.67M-56.1%
2016$15.19M+222.2%
2015$4.72M-62.3%
2014$12.52M-25.7%
2013$16.85M+126.3%
2012$7.44M+216.5%
2011$2.35M-74.6%
2010$9.26M+301.0%
2009$2.31M-52.9%
2008$4.90M—